Small Cell Lung Cancer
Advertisement
Mara B. Antonoff, MD, FACS, shares key considerations and developments in surgery for stage IV lung cancer.
Despite decades of decline, "lung cancer continues to dwarf other cancers in the number of deaths," officials said.
The TROPiCS-03 trial, a multicohort, open-label basket study, is assessing the antibody-drug conjugate in solid tumors.
Lauren Averett Byers, MD, will be honored with the award during the TAMEST Annual Conference in February.
The foundation's 2024 Scientific Grant Program awards mark the "largest single-year investment in its history.”
A new study illustrated the importance of exercise for patients with lung cancer who experience cancer-related fatigue.
The Breakthrough Therapy Designation is based on results from the ES-SCLC cohort in the global phase 2 TROPiCS-03 study.
The phase 2 expansion portion of the trial will enroll approximately 50 patients at 10 to 15 sites in the United States.
Certain groups continue to experience higher rates of lung cancer mortality related to chronic lower respiratory diseases.
Investigators evaluated the efficacy of durvalumab in the randomized, double-blind, placebo-controlled ADRIATIC trial.
Researchers evaluated the immunogenicity and safety of the COVID-19 vaccine in patients with lung cancer.
The recent report shows that the "breadth of tobacco-caused disparities continues to persist and expand."
The last Surgeon General’s report on tobacco-related disparities was released more than two decades ago in 1998.
A project led by a researcher from the Dana-Farber Cancer Center is the first to receive the four-year grant of $2.5 million.
For patients with Schlafen 11-positive ES-SCLC, atezolizumab plus talazoparib showed an PFS improvement after chemotherapy.
Deborah Brown shares key findings from the recently released seventh annual "State of Lung Cancer" report.
The campaign kicked off on November 1 to coincide with Lung Cancer Awareness Month.
Deborah Brown shares how the American Lung Association and its LUNG FORCE initiative are raising awareness this month.
Dr. Studts discusses why Lung Cancer Awareness Month is a critical time to inspire action, engagement, and hope.
The initiative is promoting lung cancer screening and efforts to fund research, as well as releasing an upcoming report.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.